NEW YORK (TheStreet) -- Humana (HUM) - Get Report stock is decreasing by 0.53% to $183.54 in late morning trading on Wednesday, after the company announced better-than-expected earnings per share results but lower-than-estimated revenue for the second quarter of 2015.

The company posted earnings of $1.67 per diluted share on revenue of $13.73 billion for the 2015 second quarter.

Analysts had expected Humana to post earnings of $1.63 per share on revenue of $13.81 billion for the second quarter of this year.

Last year, the company reported earnings of $2.19 per diluted share on revenue of $12.22 billion.

The 12.4% year-over-year increase in revenue was attributed to higher premiums, a rise in service revenues, and Medicare Advantage membership growth.

Individual Medicare Advantage membership rose 14.8% year-over-year in the quarter ended June 30 to 2.71 million.

Separately, TheStreet Ratings team rates HUMANA INC as a Buy with a ratings score of B+. TheStreet Ratings Team has this to say about their recommendation:

"We rate HUMANA INC (HUM) a BUY. This is driven by some important positives, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, increase in net income and reasonable valuation levels. We feel its strengths outweigh the fact that the company shows weak operating cash flow."

You can view the full analysis from the report here: HUM Ratings Report

Image placeholder title

HUM

data by

YCharts